Cigna Investments’s AbbVie ABBV Stock Holding History

Cigna Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.22M	Sell	16,771 -105	-0.6%	-$22.6K	0.55%	29
2026 Q1	$3.67M	Sell	16,876 -216	-1%	-$47.9K	0.56%	25
2025 Q4	$3.91M	Sell	17,092 -165	-1%	-$37.6K	0.56%	22
2025 Q3	$4M	Sell	17,257 -165	-0.9%	-$33.6K	0.56%	24
2025 Q2	$3.23M	Sell	17,422 -401	-2%	-$74.5K	0.55%	26
2025 Q1	$3.73M	Sell	17,823 -364	-2%	-$70.8K	0.69%	24
2024 Q4	$3.23M	Sell	18,187 -110	-0.6%	-$20.2K	0.56%	25
2024 Q3	$3.61M	Sell	18,297 -182	-1%	-$34K	0.64%	24
2024 Q2	$3.17M	Sell	18,479 -225	-1%	-$37.3K	0.59%	24
2024 Q1	$3.41M	Sell	18,704 -127	-0.7%	-$21.9K	0.64%	24
2023 Q4	$2.92M	Sell	18,831 -72	-0.4%	-$10.5K	0.6%	24
2023 Q3	$2.82M	Sell	18,903 -2,478	-12%	-$364K	0.64%	23
2023 Q2	$2.88M	Sell	21,381 -113	-0.5%	-$16.6K	0.53%	28
2023 Q1	$3.43M	Sell	21,494 -393	-2%	-$60.1K	0.68%	24
2022 Q4	$3.54M	Buy	21,887 +102	+0.5%	+$15.6K	0.73%	24
2022 Q3	$2.92M	Sell	21,785 -1,078	-5%	-$155K	0.65%	25
2022 Q2	$3.5M	Sell	22,863 -8,353	-27%	-$1.28M	0.7%	26
2022 Q1	$5.06M	Sell	31,216 -8,950	-22%	-$1.3M	0.62%	26
2021 Q4	$5.44M	Sell	40,166 -14,088	-26%	-$1.66M	0.43%	39
2021 Q3	$5.85M	Sell	54,254 -1,030	-2%	-$118K	0.44%	45
2021 Q2	$6.23M	Sell	55,284 -8,301	-13%	-$935K	0.44%	40
2021 Q1	$6.88M	Buy	63,585 +1,777	+3%	+$190K	0.47%	40
2020 Q4	$6.62M	Buy	61,808 +4,812	+8%	+$462K	0.51%	37
2020 Q3	$4.99M	Sell	56,996 -8,220	-13%	-$774K	0.48%	41
2020 Q2	$6.4M	Buy	65,216 +22,215	+52%	+$1.96M	0.61%	31
2020 Q1	$3.28M	Buy	43,001 +3,816	+10%	+$325K	0.42%	48
2019 Q4	$3.17M	Sell	39,185 -4,180	-10%	-$347K	0.34%	63
2019 Q3	$3.45M	Sell	43,365 -4,430	-9%	-$304K	0.36%	57
2019 Q2	$3.19M	Sell	47,795 -63	-0.1%	-$4.95K	0.35%	57
2019 Q1	$3.86M	Buy	47,858 +84	+0.2%	+$6.87K	0.43%	44
2018 Q4	$4.4M	Buy	47,774 +680	+1%	+$59.8K	0.37%	33
2018 Q3	$3.67M	Sell	47,094 -19,565	-29%	-$1.86M	0.29%	44
2018 Q2	$6.18M	Sell	66,659 -9,376	-12%	-$916K	0.45%	29
2018 Q1	$7.2M	Buy	76,035 +3,121	+4%	+$343K	0.48%	27
2017 Q4	$7.05M	Sell	72,914 -2,303	-3%	-$217K	0.46%	27
2017 Q3	$6.68M	Buy	75,217 +13,505	+22%	+$1.03M	0.45%	31
2017 Q2	$4.47M	Sell	61,712 -4,677	-7%	-$314K	0.31%	44
2017 Q1	$4.33M	Buy	66,389 +6,362	+11%	+$400K	0.3%	45
2016 Q4	$3.76M	Buy	+60,027	New	+$3.66M	0.41%	41

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cigna Investments's ABBV Position: Q2 2026 in Review

Cigna Investments reduced its AbbVie (ABBV) stake by 0.62% in Q2 2026, selling an estimated $22.6K and leaving 16,771 shares worth $4.22M. The position accounts for 0.55% of the portfolio, ranked #29.

Cigna Investments first reported a position in ABBV in Q4 2016 and has held it in 39 quarters since. The position peaked at $7.2M in Q1 2018. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Cigna Investments held 16,771 shares of AbbVie worth $4.22M as of Q2 2026.
Cigna Investments sold 105 AbbVie shares in Q2 2026, an estimated $22.6K.
AbbVie made up 0.55% of Cigna Investments's portfolio in Q2 2026, its #29 holding.
Cigna Investments first reported a position in AbbVie in Q4 2016 and has held it in 39 quarters since.
Cigna Investments's AbbVie position peaked at $7.2M in Q1 2018.
4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cigna Investments's 13F filing for Q2 2026, filed 21 Jul 2026.